APA

Barnes D. M., Bartkova J., Camplejohn R. S., Gullick W. J., Smith P. J. & Millis R. R. (19920626). Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?. : European journal of cancer (Oxford, England : 1990).

Chicago

Barnes D M, Bartkova J, Camplejohn R S, Gullick W J, Smith P J and Millis R R. 19920626. Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?. : European journal of cancer (Oxford, England : 1990).

Harvard

Barnes D. M., Bartkova J., Camplejohn R. S., Gullick W. J., Smith P. J. and Millis R. R. (19920626). Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?. : European journal of cancer (Oxford, England : 1990).

MLA

Barnes D M, Bartkova J, Camplejohn R S, Gullick W J, Smith P J and Millis R R. Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?. : European journal of cancer (Oxford, England : 1990). 19920626.